SCHEMBL12463917

SCHEMBL12463917

COc1nccc2c1ccc1occc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 3/20 0.44
▸ HTR2C P28335 3/20 0.44
▸ TRPA1 O75762 1/20 0.42
▸ DRD1 P21728 8/20 0.40
▸ KDM4E B2RXH2 4/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ CYP2C19 P33261 3/20 0.36
▸ CYP1A1 P04798 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ CYP1B1 Q16678 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ PGR P06401 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ CYP2A6 P11509 1/20 0.36
▸ KCNA2 P16389 1/20 0.36
▸ MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1901526 0.85 TRPA1 (0.54) HTR2AHTR2CTRPA1DRD1
SCHEMBL13409383 0.82 TRPA1 (0.40) HTR2AHTR2CTRPA1DRD1HTR2B
SCHEMBL8276163 0.77 HTR2C (0.40) HTR2AHTR2CTRPA1DRD1CYP2A6
SCHEMBL8271691 0.75 TRPA1 (0.41) TRPA1DRD1KDM4EALDH1A1CYP3A4
SCHEMBL15465932 0.74 PAX8 (0.45) HTR2AHTR2CKDM4EALDH1A1CYP3A4
SCHEMBL12278144 0.74 PAX8 (0.45) HTR2AHTR2CKDM4EALDH1A1CYP3A4
SCHEMBL17426271 0.74 PAX8 (0.45) HTR2AHTR2CKDM4EALDH1A1CYP3A4
SCHEMBL8272979 0.72 HTR2C (0.38) HTR2AHTR2CTRPA1DRD1MAOA
SCHEMBL8277931 0.72 HTR2C (0.45) HTR2AHTR2CTRPA1DRD1MAOA
SCHEMBL24469185 0.70 CYP1A2 (0.46) KDM4EALDH1A1CYP2C19CYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2340830-A2 Hepatitis C Virus Inhibitors Bristol-Myers Squibb Company (US) 2011-07-06 — — EP disclosed
Send feedback